Journal metric profile

Expert Opinion on Drug Discovery

Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor, five-year Impact Factor, quartile, category rank, publisher, identifiers and citation profile for the 2025 metric year.

JCR-based Impact Factor 4.900 2025 metric year
5-Year Impact Factor 6.300 Longer citation window
JCR Quartile Q1 Subject-category quartile
JCR Category Rank 48/352 Recorded category rank

Expert Opinion on Drug Discovery JCR impact factor overview

This profile summarizes the journal metrics and publication information available in the current directory record.

Page reviewed August 6, 2026

Expert Opinion on Drug Discovery metric snapshot

Expert Opinion on Drug Discovery has a bibliometric profile in this directory for 2025. The publisher recorded for the journal is TAYLOR & FRANCIS LTD. Its listed Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor is 4.900. The five-year Journal Impact Factor is 6.300, giving a second citation window for comparison. The journal is recorded in quartile Q1 for its listed JCR category.

Category position and quartile

The recorded JCR category position is 48 out of 352 journals. Based on that rank position, the journal sits within approximately the top 14% of the listed category. Its listed quartile is Q1. Category ranks and quartiles are field-specific and are not measures of the quality of an individual article.

How the citation indicators compare

The five-year Journal Impact Factor (6.300) is 1.400 points higher than the standard Journal Impact Factor (4.900). Without journal self-citations, the Impact Factor is 4.800, a difference of 0.100 points from the listed standard value. The Journal Citation Indicator (JCI) is recorded as 0.720. These measures use different definitions or citation windows, so they are most useful when read together rather than treated as interchangeable scores.

Citation and publication counts

For 2025, the directory record for Expert Opinion on Drug Discovery lists total cites: 6,666; total articles: 20; citable items: 78. These fields describe different parts of the JCR record and should not be combined into an article-level quality score.

Citation half-life profile

The cited half-life is 6.4 years, indicating the median age of items that contributed citations to the journal in the reporting framework. The citing half-life is 6 years, indicating the median age of references used by the journal’s articles.

Identifiers and verification

Expert Opinion on Drug Discovery is identified in this directory by print ISSN 1746-0441 and electronic ISSN 1746-045X. The publisher is recorded as TAYLOR & FRANCIS LTD. When making submission, library, or research-evaluation decisions, verify the title and identifiers against the journal publisher and the official Clarivate Journal Citation Reports record.

Complete journal information

Use this table to verify the individual metric values, identifiers and publication details stored for this journal.

Journal nameExpert Opinion on Drug Discovery
Abbreviated journalEXPERT OPIN DRUG DIS
PublisherTAYLOR & FRANCIS LTD
Metric year2025
Overall rank2,094
ISSN1746-0441
eISSN1746-045X
Total cites6,666
Total articles20
Citable items78
Cited half-life6.4 years
Citing half-life6 years
JCR-based Journal Impact Factor4.900
5-Year Impact Factor6.300
Impact Factor without journal self-cites4.800
Journal Citation Indicator0.720
JCR Impact Factor quartileQ1
JCR category rank48/352
Database record updated

Frequently asked questions

What is the 2025 JCR-based Journal Impact Factor of Expert Opinion on Drug Discovery?

The Journal Impact Factor recorded in this directory as a Clarivate Journal Citation Reports (JCR)-based value for Expert Opinion on Drug Discovery is 4.900 for the 2025 metric year.

What are the JCR quartile and category rank of Expert Opinion on Drug Discovery?

Expert Opinion on Drug Discovery is listed with quartile Q1 and category rank 48/352. These values are category-specific and should be verified against the official JCR record when used for formal assessment.

What is the five-year Journal Impact Factor of Expert Opinion on Drug Discovery?

The five-year Journal Impact Factor recorded for Expert Opinion on Drug Discovery is 6.300. It uses a longer citation window than the standard Journal Impact Factor.

Who publishes Expert Opinion on Drug Discovery?

Expert Opinion on Drug Discovery is listed in this directory as being published by TAYLOR & FRANCIS LTD.

Additional records from the same publisher or with a similar listed JCR Impact Factor.